Mexico · Delayed Price · Currency is MXN Kenvue Company Description
Kenvue Inc. operates as a consumer health company in the United States, rest of North America, Europe, the Middle East, Africa, the Asia-Pacific, and Latin America.
It operates in three segments: Self Care, Skin Health and Beauty, and Essential Health. The company offers over-the-counter medicine for cough, cold and allergy, pain care, digestive health, smoking cessation, and eye care, as well as other naturally inspired and self-care products, digital diagnostics, and telemedicine; face and body care, hair, sun, and other care products; oral and baby care, women’s health, wound care, and other essential health products; tampons; cosmetics; and vitamins and supplements.
It sells its products under the Benadryl, Calpol, Motrin, Nicorette, Rhinocort, Tylenol, Zarbee’s Naturals, and Zyrtec; Aveeno, Dr.Ci:Labo, Le Petit Marseillais, Lubriderm, Neutrogena, OGX, and Rogaine; BAND-AID, Carefree, Desitin, Johnson’s, Listerine, o.b., and Stayfree; and ORSL, Clean & Clear, Versalie, Benylin, Daktarin, Imodium, Johnson’s Baby, Johnson’s Adult, Maui Moisture, Microlax, Motilium, Neosporin, Neostrata, Pepcid, Pulmicort, Regaine, Sudafed, and Visine/Vispring/Visclear brands.
Kenvue Inc. was incorporated in 2022 and is headquartered in Summit, New Jersey.
| Country | United States |
| Founded | 2022 |
| Industry | Soap, Detergents, And Cleaning Preparations; Perfumes, Cosmetics, and Other Toilet Preparations |
| Employees | 21,890 |
| CEO | Kirk Perry |
Contact Details
Address: 1 Kenvue Way Summit, New Jersey 07901 United States | |
| Phone | 908-874-1200 |
| Website | kenvue.com |
Stock Details
| Ticker Symbol | KVUE |
| Exchange | Mexican Stock Exchange |
| Stock Type | Common Stock |
| Fiscal Year | January - December |
| Reporting Currency | USD |
| SIC Code | 2840 |
Key Executives
| Name | Position |
|---|---|
| Kirk Perry | Chief Executive Officer |
| Amit Banati | Chief Financial Officer |
| Meredith Stevens | Chief Operating Officer |
| Sofya Tsinis | Head of Investor Relations |